Welcome to the e-CCO Library!

P213: Raised faecal calprotectin in inflammatory bowel disease (IBD) patients: 100% accurate or potential red herring?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Christopher*1, C. Clifford1, C. White1, E. Anderson1, J. Keohane1, S. Sengupta1

Created: Friday, 22 February 2019, 9:41 AM
P213: Risk factors associated with NAFLD and liver fibrosis in patients with Inflammatory Bowel Disease: a prospective cohort study
Year: 2022
Source: ECCO'22
Authors: Martínez-Domínguez, S.J.(1,2,3);García Mateo, S.(1,2,3);Gallego Llera, B.(3);Gargallo-Puyuelo, C.J.(1,2,3);Refaie, E.(4);Arroyo Villarino, M.T.(1,2,3);Laredo de la Torre, V.(1,3);Alfambra Cabrejas, E.(3);Gomollón García, F.(1,2,3);
Created: Friday, 11 February 2022, 3:52 PM
P214 Low bone mineral density in inflammatory bowel disease patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Eddy1, S. Stanton2, K. Subramaniam1,3

Created: Thursday, 30 January 2020, 10:12 AM
P214: Cine MRI assessment of colonic motility in patients with ulcerative colitis associated constipation.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Miller, C.(1)*;Taylor, S.(2);Emmanuel, A.(1);Zarate-Lopez, N.(1);Pakpoor, J.(2);Fitzke, H.(3);Menys, A.(3);Holmes, J.(3);Atkinson, D.(3);Markus, J.(3);Blad, W.(1);Bloom, S.(1);
Created: Friday, 14 July 2023, 10:48 AM
P214: Faecal S100A12 as a non-invasive marker of inflammatory activity in pediatric Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Casertano, M.(1);Cenni, S.(2);Caprio, A.M.(1);Oglio, F.(2);Pacella, D.(2);Miele, E.(2);Martinelli, M.(2);Staiano, A.(2);Strisciuglio, C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P214: How to incorporate patients preference into ulcerative colitis current clinical management: initial document from a Spanish multidisciplinary steering committee
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

F. Casellas*1, D. Ginard2, S. García-López3, Y. González-Lama4, F. Arguelles-Arias5, M. Barreiro-de Acosta6, L. Marín Sánchez7, J. M. Mendive8, R. Saldaña9

Created: Friday, 22 February 2019, 9:41 AM
P214: Inflammatory bowel disease and endometriosis: is there a relationship?
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Fortuna*1, A. Variola2, R. Montanari2, G. Ruffo3, P. Bocus4, A. Geccherle2

Created: Friday, 22 February 2019, 9:49 AM
P214: Long-term outcomes of paediatric patients admitted for Acute Severe Colitis - a multicentre study from the paediatric IBD porto group of ESPGHAN
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Krauthammer1, C. Tzivinikos2, A. Assa3, E. Miele4, C. Strisciuglio5, O. Ledder6, I. Shamasneh6, D. Serban7, I. Hojsak8, M. Malham9, T. de Meij10, V. Dipasquale11, C. Romano11, N.A. Afzal12, M. Aloi13, K.Y. Lee14, A. Yerushalmy15, B. Weiss1, D. Shouval1*

Created: Thursday, 21 February 2019, 9:14 AM
P214: Plasma fatty acid binding protein 2, interleukin-10 and lipopolysaccharides as biomarkers for microscopic colitis
Year: 2022
Source: ECCO'22
Authors: Vytautas, K.(1);Varkalaite, G.(2);Vaitkeviciute, E.(2);Arstikyte, J.(2);Skieceviciene, J.(2);Kupcinskas, J.(1);
Created: Friday, 11 February 2022, 3:52 PM
P214: What is the diagnostic accuracy of faecal calprotectin regarding endoscopic relapse in Crohn's disease patients following ileocecal resection? A tertiary single center experience
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Yıldırım S., Demir N., Bozcan S., Erzin Y., Hatemi I., Celik A.F.

Created: Wednesday, 20 February 2019, 10:36 AM
P215 The effect of resection margin involvement of Crohn’s disease on the surgical and clinical recurrence after intestinal surgery
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.H. Seo, J.L. Lee

Created: Thursday, 30 January 2020, 10:12 AM
P215: Blood-based prognostic biomarkers in Crohn’s patients treated with biologics: a new promising tool to predict endoscopic outcomes
Year: 2021
Source: ECCO'21 Virtual
Authors: Grova, M.(1,2);Crispino, F.(1,2);Maida, M.(3);Renna, S.(1);Mocciaro, F.(4);Casà, A.(1);Rizzuto, G.(1);Scimeca, D.(4);Di Mitri, R.(4);Macaluso, F.S.(1);Orlando, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P215: Clinical features of chronic enteropathy associated with SLCO2A1 gene (CEAS)
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Umeno J.*1, Esaki M.1, Hirano A.1, Hisamatsu T.2, Watanabe K.3, Hirai F.4, Matsui T.4, Hibi T.5, Kitazono T.1, Matsumoto T.1,6

Created: Wednesday, 20 February 2019, 10:36 AM
P215: Correlation between small bowel capsule endoscopy and biomarkers in postoperative recurrence in Crohn’s Disease
Year: 2022
Source: ECCO'22
Authors: Elosua Gonzalez, A.(1);Rullan, M.(1);Rubio, S.(2);Oquiñena, S.(2);Macías, E.(2);Elizalde, I.(2);Vicuña, M.(2);Aznárez, M.R.(2);Juanmartiñena, J.F.(2);Borda, A.(2);Rodriguez, C.(2);Fernández-Urién, I.(2);Nantes, Ó.(2);
Created: Friday, 11 February 2022, 3:52 PM
P215: Deep immune phenotyping of unconventional T cells reveals a depletion in Mucosa Associated T Cells (MAIT) in IBD patients with extraintestinal manifestations
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Catalàn-Serrax, I.(1,2,3)*;Xu, W.(4);Bruland, T.(5);Larbi, A.(6);Sandvik, A.K.(5,7,8);
Created: Friday, 14 July 2023, 10:48 AM
P215: The determination of anti-saccharomyces cerevisiae antibodies at diagnosis of Crohn’s disease allows selecting a group of patients with higher risk of developing a complicated behaviour: A prospective study
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. de Francisco1,2*, P. Flórez-Díez1, A. Castaño1, S. Martínez-González1, P. Olivares1, I. Pérez-Martínez1, L. Mozo3, A. Suárez1,2, S. Riestra1,2

Created: Thursday, 21 February 2019, 9:14 AM
P215: The influence of disease activity on birth outcomes in patients with inflammatory bowel disease: Meta- analysis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. J. Park*1, H. J. Kim2, M.-A. Kim3

Created: Friday, 22 February 2019, 9:49 AM
P215: The mean platelet volume compared with other serum biomarkers: is it predictive of activity of Crohn’s disease?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H. Ben Jeddi*1, H. Kchir1, A. Hassine1, D. Issaoui1, H. Chaabouni1, N. Maamouri1

Created: Friday, 22 February 2019, 9:41 AM
P216 Anti-drug antibodies to infliximab: A comparison of free anti-drug antibody measurement
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Hamilton1, S. Shields2, J. MacDonald2, A. Dunlop1, M. Perry3, A. McGucken3, E. Gribben4, P. Galloway1

Created: Thursday, 30 January 2020, 10:12 AM
P216: Comparative Assessment C-reactive Protein Between a Point-of-Care Testing and Current Standard of Care (Immunonephelometric testing)
Year: 2021
Source: ECCO'21 Virtual
Authors: Lorenzon, G.(1);Marsilio, I.(1);Maniero, D.(1);Rigo, A.(1);Barberio, B.(1);Zingone, F.(1);Bahur, B.(2);Bray , K.R.(3);Savarino, E.V.(1);
Created: Wednesday, 2 June 2021, 4:12 PM